share_log

Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021

Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021

Benzinga的最高評級上調,2021年9月23日評級下調
Benzinga Real-time News ·  2021/09/23 10:06

 

Upgrades

升級

  • Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:WMG) from Equal-Weight to Overweight. Warner Music Group earned $0.16 in the third quarter, compared to $0.04 in the year-ago quarter. The current stock performance of Warner Music Group shows a 52-week-high of $45.64 and a 52-week-low of $25.61. Moreover, at the end of the last trading period, the closing price was at $43.22.

  • According to Deutsche Bank, the prior rating for Equity Residential (NYSE:EQR) was changed from Sell to Hold. In the second quarter, Equity Residential showed an EPS of $0.72, compared to $0.86 from the year-ago quarter. The current stock performance of Equity Residential shows a 52-week-high of $86.04 and a 52-week-low of $45.42. Moreover, at the end of the last trading period, the closing price was at $81.37.

  • For AvalonBay Communities Inc (NYSE:AVB), Deutsche Bank upgraded the previous rating of Sell to Hold. For the second quarter, AvalonBay Communities had an EPS of $1.98, compared to year-ago quarter EPS of $2.23. The stock has a 52-week-high of $233.48 and a 52-week-low of $131.38. At the end of the last trading period, AvalonBay Communities closed at $223.48.

  • According to Goldman Sachs, the prior rating for Northrop Grumman Corp (NYSE:NOC) was changed from Sell to Neutral. Northrop Grumman earned $6.42 in the second quarter, compared to $6.01 in the year-ago quarter. The stock has a 52-week-high of $379.03 and a 52-week-low of $282.88. At the end of the last trading period, Northrop Grumman closed at $348.52.

  • For General Dynamics Corp (NYSE:GD), Goldman Sachs upgraded the previous rating of Sell to Neutral. General Dynamics earned $2.61 in the second quarter, compared to $2.18 in the year-ago quarter. The current stock performance of General Dynamics shows a 52-week-high of $206.46 and a 52-week-low of $129.17. Moreover, at the end of the last trading period, the closing price was at $193.75.

  • Truist Securities upgraded the previous rating for RBC Bearings Inc (NASDAQ:ROLL) from Hold to Buy. RBC Bearings earned $1.04 in the first quarter, compared to $0.95 in the year-ago quarter. At the moment, the stock has a 52-week-high of $250.52 and a 52-week-low of $113.40. RBC Bearings closed at $199.57 at the end of the last trading period.

  • For Roku Inc (NASDAQ:ROKU), Guggenheim upgraded the previous rating of Neutral to Buy. For the second quarter, Roku had an EPS of $0.52, compared to year-ago quarter EPS of $0.35. At the moment, the stock has a 52-week-high of $490.76 and a 52-week-low of $176.63. Roku closed at $324.77 at the end of the last trading period.

  • According to Raymond James, the prior rating for Ventas Inc (NYSE:VTR) was changed from Outperform to Strong Buy. In the second quarter, Ventas showed an EPS of $0.73, compared to $0.77 from the year-ago quarter. At the moment, the stock has a 52-week-high of $61.09 and a 52-week-low of $37.83. Ventas closed at $56.21 at the end of the last trading period.

  • According to SVB Leerink, the prior rating for Incyte Corp (NASDAQ:INCY) was changed from Underperform to Market Perform. For the second quarter, Incyte had an EPS of $0.80, compared to year-ago quarter EPS of $1.24. The stock has a 52-week-high of $101.47 and a 52-week-low of $69.42. At the end of the last trading period, Incyte closed at $69.59.

  • For ONEOK Inc (NYSE:OKE), Bernstein upgraded the previous rating of Market Perform to Outperform. For the second quarter, ONEOK had an EPS of $0.77, compared to year-ago quarter EPS of $0.32. At the moment, the stock has a 52-week-high of $57.55 and a 52-week-low of $23.28. ONEOK closed at $54.85 at the end of the last trading period.

  • For Plug Power Inc (NASDAQ:PLUG), Piper Sandler upgraded the previous rating of Neutral to Overweight. For the second quarter, Plug Power had an EPS of $0.18, compared to year-ago quarter EPS of $0.03. The current stock performance of Plug Power shows a 52-week-high of $75.49 and a 52-week-low of $10.92. Moreover, at the end of the last trading period, the closing price was at $26.92.

  • 巴克萊上調了之前的評級為華納音樂集團(Warner Music Group Corp)(納斯達克:WMG從等重到超重。華納音樂集團(Warner Music Group)第三季度盈利0.16美元,而去年同期為0.04美元。華納音樂集團目前的股票表現顯示,52周高點為45.64美元,52周低點為25.61美元。而且,在上個交易期結束時,收盤價為43.22美元。

  • 根據德意志銀行(Deutsche Bank)的先前評級,股權住宅紐約證券交易所代碼:EQR)從賣出改為持有。第二季度,Equity Residential顯示每股收益為0.72美元,而去年同期為0.86美元。目前Equity Residential的股票表現顯示為86.04美元的52周高點和45.42美元的52周低點。而且,在上個交易期結束時,收盤價為81.37美元。

  • AvalonBay社區公司紐約證券交易所代碼:AVB),德意志銀行將之前的評級上調為賣出至持有。第二季度,AvalonBay Communities的每股收益為1.98美元,而去年同期為2.23美元。該股目前的52周高點為233.48美元,52周低點為131.38美元。上個交易期結束時,AvalonBay Communities收於223.48美元。

  • 根據高盛(Goldman Sachs)的説法,之前的評級為諾斯羅普·格魯曼公司紐約證券交易所代碼:NoC)從賣出改為中性。諾斯羅普·格魯曼公司第二季度的利潤為6.42美元,而去年同期為6.01美元。該股目前的52周高點為379.03美元,52周低點為282.88美元。上個交易期尾盤,諾斯羅普·格魯曼公司收報348.52美元。

  • 通用動力公司紐約證券交易所代碼:GD),高盛將之前的評級上調為賣出至中性。通用動力公司第二季度的利潤為2.61美元,而去年同期為2.18美元。通用動力目前的股票表現顯示,52周高點為206.46美元,52周低點為129.17美元。而且,在上個交易期結束時,收盤價為193.75美元。

  • Truist Securities上調了之前的評級,RBC軸承公司(納斯達克:滾筒)從持有到買入。加拿大皇家銀行軸承公司第一季度的利潤為1.04美元,而去年同期為0.95美元。目前,該股的52周高點為250.52美元,52周低點為113.40美元。加拿大皇家銀行軸承上一交易期尾盤報199.57美元。

  • Roku Inc.(納斯達克:羅庫),Guggenheim將之前的中性評級上調至買入。第二季度,Roku的每股收益為0.52美元,而去年同期為0.35美元。目前,該股的52周高點為490.76美元,52周低點為176.63美元。樂庫上交易期尾盤報324.77美元。

  • 根據雷蒙德·詹姆斯(Raymond James)的説法,之前的評級為文塔斯公司(Ventas Inc.)紐約證券交易所代碼:錄像機)從跑贏大盤轉為強勢買入。第二季度,Ventas顯示每股收益為0.73美元,而去年同期為0.77美元。目前,該股的52周高點為61.09美元,52周低點為37.83美元。Ventas上一交易期尾盤報56.21美元。

  • 根據SVB Leerink的數據,之前的評級為Incell公司(納斯達克:INCY)從表現不佳改為市場表現。第二季度,Incell的每股收益為0.80美元,而去年同期為1.24美元。該股目前的52周高點為101.47美元,52周低點為69.42美元。上交易期尾盤,Incell收報69.59美元。

  • ONEOK Inc.紐約證券交易所代碼:好的),伯恩斯坦將之前對市場表現的評級上調至表現優於大盤。第二季度,ONEOK的每股收益為0.77美元,而去年同期為0.32美元。目前,該股的52周高點為57.55美元,52周低點為23.28美元。ONEOK上一交易期尾盤報54.85美元。

  • Plug Power Inc.(納斯達克:插頭),Piper Sandler將之前的評級上調為中性至加碼。第二季度,Plug Power的每股收益為0.18美元,而去年同期為0.03美元。Plug Power目前的股票表現顯示,52周高點為75.49美元,52周低點為10.92美元。而且,在上個交易期結束時,收盤價為26.92美元。

 

Downgrades

降級

  • For Delta Air Lines Inc (NYSE:DAL), Argus Research downgraded the previous rating of Buy to Hold. In the second quarter, Delta Air Lines showed an EPS of $1.07, compared to $4.43 from the year-ago quarter. The stock has a 52-week-high of $52.28 and a 52-week-low of $27.92. At the end of the last trading period, Delta Air Lines closed at $41.59.

  • William Blair downgraded the previous rating for Eargo Inc (NASDAQ:EAR) from Outperform to Market Perform. Interestingly, in the second quarter, Eargo's EPS was $0.36. At the moment, the stock has a 52-week-high of $76.75 and a 52-week-low of $19.25. Eargo closed at $21.67 at the end of the last trading period.

  • According to Goldman Sachs, the prior rating for Lockheed Martin Corp (NYSE:LMT) was changed from Buy to Neutral. In the second quarter, Lockheed Martin showed an EPS of $6.52, compared to $5.79 from the year-ago quarter. The current stock performance of Lockheed Martin shows a 52-week-high of $396.99 and a 52-week-low of $319.81. Moreover, at the end of the last trading period, the closing price was at $341.73.

  • According to Goldman Sachs, the prior rating for L3Harris Technologies Inc (NYSE:LHX) was changed from Neutral to Sell. L3Harris Technologies earned $3.26 in the second quarter, compared to $2.83 in the year-ago quarter. At the moment, the stock has a 52-week-high of $235.10 and a 52-week-low of $158.09. L3Harris Technologies closed at $222.73 at the end of the last trading period.

  • According to B of A Securities, the prior rating for CommScope Holding Co Inc (NASDAQ:COMM) was changed from Buy to Neutral. In the second quarter, CommScope Hldg Co showed an EPS of $0.43, compared to $0.32 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.18 and a 52-week-low of $8.25. CommScope Hldg Co closed at $13.77 at the end of the last trading period.

  • For Amgen Inc (NASDAQ:AMGN), Daiwa Capital downgraded the previous rating of Outperform to Neutral. For the second quarter, Amgen had an EPS of $4.38, compared to year-ago quarter EPS of $4.25. The current stock performance of Amgen shows a 52-week-high of $276.69 and a 52-week-low of $210.28. Moreover, at the end of the last trading period, the closing price was at $213.64.

  • According to Baird, the prior rating for Signify Health Inc (NYSE:SGFY) was changed from Outperform to Neutral. Signify Health earned $0.00 in the second quarter. At the moment, the stock has a 52-week-high of $40.79 and a 52-week-low of $21.00. Signify Health closed at $21.44 at the end of the last trading period.

  • According to Morgan Stanley, the prior rating for Trimble Inc (NASDAQ:TRMB) was changed from Equal-Weight to Underweight. For the second quarter, Trimble had an EPS of $0.72, compared to year-ago quarter EPS of $0.52. The current stock performance of Trimble shows a 52-week-high of $96.49 and a 52-week-low of $46.78. Moreover, at the end of the last trading period, the closing price was at $90.54.

  • For Vipshop Holdings Ltd (NYSE:VIPS), JP Morgan downgraded the previous rating of Overweight to Neutral. For the second quarter, Vipshop Holdings had an EPS of $0.32, compared to year-ago quarter EPS of $0.27. At the moment, the stock has a 52-week-high of $46.00 and a 52-week-low of $11.96. Vipshop Holdings closed at $12.73 at the end of the last trading period.

  • 達美航空公司紐約證券交易所代碼:DAL),Argus Research將之前的買入評級下調至持有。達美航空(Delta Air Lines)第二季度每股收益為1.07美元,而去年同期為4.43美元。該股52周高點為52.28美元,52周低點為27.92美元。上交易期尾盤,達美航空收報41.59美元。

  • 威廉·布萊爾下調了之前的評級,Eargo Inc.(納斯達克:耳朵)從跑贏大盤到大盤表現。有趣的是,在第二季度,Eargo的每股收益為0.36美元。目前,該股的52周高點為76.75美元,52周低點為19.25美元。Eargo上交易期尾盤報21.67美元。

  • 根據高盛(Goldman Sachs)的説法,之前的評級為洛克希德馬丁紐約證券交易所代碼:LMT)從買入改為中性。第二季度,洛克希德·馬丁公司(Lockheed Martin)的每股收益為6.52美元,而去年同期為5.79美元。洛克希德馬丁目前的股票表現顯示,52周高點為396.99美元,52周低點為319.81美元。而且,在上個交易期結束時,收盤價為341.73美元。

  • 根據高盛(Goldman Sachs)的説法,之前的評級為L3Harris Technologies Inc.紐約證券交易所代碼:1hx)從中性改為賣出。L3Harris Technologies第二季度盈利3.26美元,而去年同期為2.83美元。目前,該股的52周高點為235.10美元,52周低點為158.09美元。L3Harris Technologies上交易日尾盤報222.73美元。

  • 根據美銀美林(B Of A Securities)的説法,該公司的優先評級為CommScope Holding Co Inc.(納斯達克:通信)從買入改為中性。CommScope Hldg Co第二季EPS為0.43美元,上年同期為0.32美元.目前,該股的52周高點為22.18美元,52周低點為8.25美元。CommScope Hldg Co上一交易期尾盤收報13.77美元。

  • 安進(納斯達克:AMGN),大和資本將此前評級下調至表現優於大盤至中性。第二季度,安進的每股收益為4.38美元,而去年同期為4.25美元。安進目前的股票表現顯示,52周高點為276.69美元,52周低點為210.28美元。而且,在上個交易期結束時,收盤價為213.64美元。

  • 根據Baird的説法,之前的評級為象徵健康公司紐約證券交易所代碼:SGFY)從跑贏大盤改為中性。Signify Health在第二季度盈利0.00美元。目前,該股的52周高點為40.79美元,52周低點為21.00美元。Signify Health在上一交易期結束時收於21.44美元。

  • 據摩根士丹利介紹,該公司此前的評級為Trimble Inc.(納斯達克:TRMB)從等重改為減重。第二季度,Trimble的每股收益為0.72美元,而去年同期為0.52美元。Trimble目前的股票表現顯示52周高點96.49美元和52周低點46.78美元。而且,在上個交易期結束時,收盤價為90.54美元。

  • 唯品會控股有限公司紐約證券交易所代碼:貴賓),JP摩根將之前的評級下調至增持至中性。唯品會第二季度每股收益為0.32美元,而去年同期為0.27美元。目前,該股的52周高點為46.00美元,52周低點為11.96美元。唯品會控股上一交易期尾盤報12.73美元。

 

Initiations

啟蒙行動

  • Goldman Sachs initiated coverage on Equity Residential (NYSE:EQR) with a Neutral rating. The price target for Equity Residential is set to $86.00. In the second quarter, Equity Residential showed an EPS of $0.72, compared to $0.86 from the year-ago quarter. The stock has a 52-week-high of $86.04 and a 52-week-low of $45.42. At the end of the last trading period, Equity Residential closed at $81.37.

  • Canaccord Genuity initiated coverage on Hut 8 Mining Corp (NASDAQ:HUT) with a Buy rating. The price target for Hut 8 Mining is set to $12.00. Hut 8 Mining earned $0.02 in the second quarter, compared to $0.03 in the year-ago quarter. The current stock performance of Hut 8 Mining shows a 52-week-high of $11.30 and a 52-week-low of $3.15. Moreover, at the end of the last trading period, the closing price was at $8.64.

  • With an Underweight rating, Morgan Stanley initiated coverage on Xerox Holdings Corp (NASDAQ:XRX). The price target seems to have been set at $17.00 for Xerox Holdings. In the second quarter, Xerox Holdings showed an EPS of $0.47, compared to $0.15 from the year-ago quarter. The current stock performance of Xerox Holdings shows a 52-week-high of $26.96 and a 52-week-low of $17.05. Moreover, at the end of the last trading period, the closing price was at $20.32.

  • Tudor Pickering initiated coverage on Tesla Inc (NASDAQ:TSLA) with a Sell rating. The price target for Tesla is set to $537.00. Tesla earned $1.45 in the second quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $900.40 and a 52-week-low of $351.30. At the end of the last trading period, Tesla closed at $751.94.

  • Alliance Global Partners initiated coverage on Safe-T Group Ltd (NASDAQ:SFET) with a Buy rating. The price target for Safe-T Gr is set to $2.00. For the second quarter, Safe-T Gr had an EPS of $0.00, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $2.98 and a 52-week-low of $0.90. Safe-T Gr closed at $1.15 at the end of the last trading period.

  • With a Equal-Weight rating, Morgan Stanley initiated coverage on PLAYSTUDIOS Inc (NASDAQ:MYPS). The price target seems to have been set at $5.25 for PLAYSTUDIOS. In the second quarter, PLAYSTUDIOS showed an EPS of $0.07, compared to $0.13 from the year-ago quarter. The current stock performance of PLAYSTUDIOS shows a 52-week-high of $8.62 and a 52-week-low of $3.92. Moreover, at the end of the last trading period, the closing price was at $4.81.

  • With an Outperform rating, Cowen & Co. initiated coverage on Danimer Scientific Inc (NYSE:DNMR). The price target seems to have been set at $21.00 for Danimer Scientific. Danimer Scientific earned $0.37 in the second quarter. At the moment, the stock has a 52-week-high of $66.30 and a 52-week-low of $13.07. Danimer Scientific closed at $15.84 at the end of the last trading period.

  • With an Outperform rating, Cowen & Co. initiated coverage on PureCycle Technologies Inc (NASDAQ:PCT). The price target seems to have been set at $31.00 for PureCycle Technologies. Interestingly, in the second quarter, PureCycle Technologies's EPS was $0.13. The stock has a 52-week-high of $35.75 and a 52-week-low of $10.06. At the end of the last trading period, PureCycle Technologies closed at $12.99.

  • Wolfe Research initiated coverage on Brixmor Property Group Inc (NYSE:BRX) with a Peer Perform rating. The price target for Brixmor Property Group is set to $25.00. In the second quarter, Brixmor Property Group showed an EPS of $0.46, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $24.42 and a 52-week-low of $10.58. At the end of the last trading period, Brixmor Property Group closed at $23.23.

  • With an Outperform rating, FBN Securities initiated coverage on Rapid7 Inc (NASDAQ:RPD). The price target seems to have been set at $140.00 for Rapid7. Rapid7 earned $0.07 in the second quarter, compared to $0.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $125.32 and a 52-week-low of $58.38. Rapid7 closed at $119.08 at the end of the last trading period.

  • With a Buy rating, JonesTrading initiated coverage on Landos Biopharma Inc (NASDAQ:LABP). The price target seems to have been set at $39.00 for Landos Biopharma. In the second quarter, Landos Biopharma earned $0.12. The current stock performance of Landos Biopharma shows a 52-week-high of $16.99 and a 52-week-low of $8.82. Moreover, at the end of the last trading period, the closing price was at $15.00.

  • With an Overweight rating, Wells Fargo initiated coverage on Chart Industries Inc (NYSE:GTLS). The price target seems to have been set at $230.00 for Chart Industries. Chart Industries earned $0.80 in the second quarter, compared to $0.63 in the year-ago quarter. At the moment, the stock has a 52-week-high of $198.09 and a 52-week-low of $63.62. Chart Industries closed at $194.15 at the end of the last trading period.

  • With a Buy rating, Seaport Global initiated coverage on Ovintiv Inc (NYSE:OVV). The price target seems to have been set at $42.00 for Ovintiv. For the second quarter, Ovintiv had an EPS of $1.11, compared to year-ago quarter EPS of $0.43. At the moment, the stock has a 52-week-high of $33.46 and a 52-week-low of $6.81. Ovintiv closed at $29.59 at the end of the last trading period.

  • With a Buy rating, HC Wainwright & Co. initiated coverage on Bit Digital Inc (NASDAQ:BTBT). The price target seems to have been set at $14.00 for Bit Digital. Interestingly, in the second quarter, Bit Digital's EPS was $0.15. The current stock performance of Bit Digital shows a 52-week-high of $33.00 and a 52-week-low of $3.40. Moreover, at the end of the last trading period, the closing price was at $9.59.

  • Piper Sandler initiated coverage on Bloom Energy Corp (NYSE:BE) with a Neutral rating. The price target for Bloom Energy is set to $21.00. For the second quarter, Bloom Energy had an EPS of $0.23, compared to year-ago quarter EPS of $0.23. The current stock performance of Bloom Energy shows a 52-week-high of $44.95 and a 52-week-low of $12.37. Moreover, at the end of the last trading period, the closing price was at $19.28.

  • Loop Capital initiated coverage on Regal Beloit Corp (NYSE:RBC) with a Buy rating. The price target for Regal Beloit is set to $180.00. In the second quarter, Regal Beloit showed an EPS of $2.28, compared to $0.95 from the year-ago quarter. At the moment, the stock has a 52-week-high of $159.64 and a 52-week-low of $91.82. Regal Beloit closed at $139.83 at the end of the last trading period.

  • With a Hold rating, Loop Capital initiated coverage on The Timken Co (NYSE:TKR). The price target seems to have been set at $72.00 for Timken. In the second quarter, Timken showed an EPS of $1.37, compared to $1.02 from the year-ago quarter. The stock has a 52-week-high of $92.39 and a 52-week-low of $52.51. At the end of the last trading period, Timken closed at $66.61.

  • With a Buy rating, Stifel initiated coverage on Repare Therapeutics Inc (NASDAQ:RPTX). The price target seems to have been set at $48.00 for Repare Therapeutics. Repare Therapeutics earned $0.71 in the second quarter, compared to $2.45 in the year-ago quarter. The current stock performance of Repare Therapeutics shows a 52-week-high of $46.44 and a 52-week-low of $21.76. Moreover, at the end of the last trading period, the closing price was at $28.48.

  • With a Buy rating, Stifel initiated coverage on Mirati Therapeutics Inc (NASDAQ:MRTX). The price target seems to have been set at $202.00 for Mirati Therapeutics. In the second quarter, Mirati Therapeutics showed an EPS of $3.23, compared to $1.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of $249.42 and a 52-week-low of $131.47. Mirati Therapeutics closed at $167.10 at the end of the last trading period.

  • Stifel initiated coverage on Kinnate Biopharma Inc (NASDAQ:KNTE) with a Buy rating. The price target for Kinnate Biopharma is set to $32.00. Kinnate Biopharma earned $0.49 in the second quarter, compared to $2.05 in the year-ago quarter. The stock has a 52-week-high of $48.75 and a 52-week-low of $17.58. At the end of the last trading period, Kinnate Biopharma closed at $23.44.

  • With a Buy rating, Needham initiated coverage on Jazz Pharmaceuticals PLC (NASDAQ:JAZZ). The price target seems to have been set at $220.00 for Jazz Pharmaceuticals. For the second quarter, Jazz Pharmaceuticals had an EPS of $3.90, compared to year-ago quarter EPS of $3.71. The current stock performance of Jazz Pharmaceuticals shows a 52-week-high of $189.00 and a 52-week-low of $127.80. Moreover, at the end of the last trading period, the closing price was at $129.55.

  • Needham initiated coverage on Avadel Pharmaceuticals PLC (NASDAQ:AVDL) with a Buy rating. The price target for Avadel Pharmaceuticals is set to $17.00. For the second quarter, Avadel Pharmaceuticals had an EPS of $0.33, compared to year-ago quarter EPS of $0.12. At the moment, the stock has a 52-week-high of $10.32 and a 52-week-low of $4.83. Avadel Pharmaceuticals closed at $8.19 at the end of the last trading period.

  • With a Buy rating, Needham initiated coverage on Sage Therapeutics Inc (NASDAQ:SAGE). The price target seems to have been set at $84.00 for Sage Therapeutics. In the second quarter, Sage Therapeutics showed an EPS of $1.83, compared to $2.08 from the year-ago quarter. The current stock performance of Sage Therapeutics shows a 52-week-high of $98.39 and a 52-week-low of $39.77. Moreover, at the end of the last trading period, the closing price was at $44.35.

  • Needham initiated coverage on Intra-Cellular Therapies Inc (NASDAQ:ITCI) with a Buy rating. The price target for Intra-Cellular Therapies is set to $55.00. Intra-Cellular Therapies earned $0.85 in the second quarter, compared to $0.96 in the year-ago quarter. The current stock performance of Intra-Cellular Therapies shows a 52-week-high of $44.80 and a 52-week-low of $22.91. Moreover, at the end of the last trading period, the closing price was at $37.17.

  • With a Buy rating, Needham initiated coverage on Harmony Biosciences Holdings Inc (NASDAQ:HRMY). The price target seems to have been set at $57.00 for Harmony Biosciences. Interestingly, in the second quarter, Harmony Biosciences's EPS was $0.54. The stock has a 52-week-high of $52.74 and a 52-week-low of $25.09. At the end of the last trading period, Harmony Biosciences closed at $37.46.

  • Needham initiated coverage on Biogen Inc (NASDAQ:BIIB) with a Buy rating. The price target for Biogen is set to $400.00. For the second quarter, Biogen had an EPS of $5.68, compared to year-ago quarter EPS of $10.26. At the moment, the stock has a 52-week-high of $468.55 and a 52-week-low of $223.25. Biogen closed at $289.32 at the end of the last trading period.

  • 高盛(Goldman Sachs)在股權住宅紐約證券交易所代碼:EQR),評級為中性。Equity Residential的目標價定為86.00美元。第二季度,Equity Residential顯示每股收益為0.72美元,而去年同期為0.86美元。該股目前的52周高點為86.04美元,52周低點為45.42美元。上交易期尾盤,Equity Residential收報81.37美元。

  • Canaccel Genuity開始覆蓋小屋8礦業公司(納斯達克:小屋),評級為買入。Hut 8 Mining的目標價定為12.00美元。Hut 8 Mining第二季度盈利0.02美元,而去年同期為0.03美元。Hut 8 Mining目前的股票表現顯示,52周高點為11.30美元,52周低點為3.15美元。而且,在上個交易期結束時,收盤價為8.64美元。

  • 在減持評級的情況下,摩根士丹利啟動了對施樂控股公司(納斯達克:XRX)。施樂控股的目標價似乎被設定在17.00美元。第二季度,施樂控股(Xerox Holdings)的每股收益為0.47美元,而去年同期為0.15美元。施樂控股目前的股票表現顯示,52周高點為26.96美元,52周低點為17.05美元。而且,在上個交易期結束時,收盤價為20.32美元。

  • Tudor Pickering在特斯拉公司(納斯達克:特拉斯),並給予賣出評級。特斯拉的目標價定為537.00美元。特斯拉第二季度盈利1.45美元,而去年同期為0.44美元。該股目前的52周高點為900.40美元,52周低點為351.30美元。上交易期尾盤,特斯拉收報751.94美元。

  • Alliance Global Partners在外管局-T集團有限公司(納斯達克:SFET),評級為買入。Safe-T Gr的目標價定為2.00美元。第二季度,SAFE-T Gr的每股收益為0.00美元,而去年同期為0.01美元。目前,該股的52周高點為2.98美元,52周低點為0.90美元。SAFE-T Gr上交易日尾盤報1.15美元。

  • 在同等權重的評級下,摩根士丹利啟動了對PLAYSTUDIOS Inc.(納斯達克:MYPS)。PLAYSTUDIOS的目標價格似乎被設定在5.25美元。第二季度,PLAYSTUDIOS顯示每股收益為0.07美元,而去年同期為0.13美元。PLAYSTUDIOS目前的股票表現顯示,52周高點為8.62美元,52周低點為3.92美元。而且,在上個交易期結束時,收盤價為4.81美元。

  • 憑藉強於大盤的評級,Cowen&Co.在丹尼默科學公司紐約證券交易所代碼:DNMR)。丹尼默科學公司的目標價似乎被設定在21.00美元。丹尼默科學公司第二季度的利潤為0.37美元。目前,該股的52周高點為66.30美元,52周低點為13.07美元。DAnimer Science上一交易期尾盤報15.84美元。

  • 憑藉強於大盤的評級,Cowen&Co.在PureCycle Technologies Inc.(納斯達克:%)。PureCycle Technologies的目標價似乎被設定在31.00美元。有趣的是,在第二季度,PureCycle Technologies的每股收益為0.13美元。該股目前的52周高點為35.75美元,52周低點為10.06美元。上交易期尾盤,PureCycle Technologies收報12.99美元。

  • Wolfe Research發起了關於Brixmor Property Group Inc.紐約證券交易所代碼:BRX),具有Peer Performance(同行性能)評級。Brixmor Property Group的目標價定為25.00美元。第二季度,Brixmor Property Group顯示每股收益為0.46美元,而去年同期為0.32美元。該股目前的52周高點為24.42美元,52周低點為10.58美元。上一交易期尾盤,Brixmor Property Group收報23.23美元。

  • 憑藉強於大盤的評級,FBN Securities於Rapid7 Inc.(納斯達克:RPD)。Rapid7的目標價格似乎被設定在140.00美元。Rapid7第二季度的利潤為0.07美元,而去年同期為0.05美元。目前,該股的52周高點為125.32美元,52周低點為58.38美元。Rapid7上交易日尾盤收報119.08美元。

  • 在獲得買入評級的情況下,Jones Trading在Landos Biophma Inc.(納斯達克:LABP)。蘭多斯Biophma的目標價似乎被設定在39.00美元。第二季度,Landos Biophma盈利0.12美元。目前,Landos Biophma的股票表現顯示,52周高點為16.99美元,52周低點為8.82美元。而且,在上個交易期結束時,收盤價為15.00美元。

  • 由於增持評級,富國銀行(Wells Fargo)在查特工業公司紐約證券交易所代碼:GTLS)。查特工業的目標價似乎被設定在230.00美元。查特工業公司第二季度的利潤為0.80美元,而去年同期為0.63美元。目前,該股的52周高點為198.09美元,52周低點為63.62美元。查特工業上交易期尾盤收報194.15美元。

  • 憑藉買入評級,Seaport Global在奧文蒂夫公司紐約證券交易所代碼:OVV)。奧文蒂夫的目標價似乎被設定在42.00美元。第二季度,Ovintiv的每股收益為1.11美元,而去年同期為0.43美元。目前,該股的52周高點為33.46美元,52周低點為6.81美元。Ovintiv上交易日尾盤報29.59美元。

  • 憑藉買入評級,HC Wainwright&Co.在比特數字公司(納斯達克:BTBT)。比特數字的目標價似乎被設定在14.00美元。有趣的是,在第二季度,比特數碼的每股收益為0.15美元。BIT Digital目前的股票表現顯示,52周高點為33.00美元,52周低點為3.40美元。而且,在上個交易期結束時,收盤價為9.59美元。

  • 派珀·桑德勒(Piper Sandler)在布魯姆能源公司紐約證券交易所代碼:),評級為中性。Bloom Energy的目標價定為21.00美元。第二季度,Bloom Energy的每股收益為0.23美元,而去年同期為0.23美元。Bloom Energy目前的股票表現顯示,52周高點為44.95美元,52周低點為12.37美元。而且,在上個交易期結束時,收盤價為19.28美元。

  • Loop Capital在富豪貝洛伊特公司紐約證券交易所代碼:紅細胞),評級為買入。富豪貝洛伊特的目標價定為180.00美元。第二季度,富豪貝洛伊特(Regal Beloit)的每股收益為2.28美元,而去年同期為0.95美元。目前,該股的52周高點為159.64美元,52周低點為91.82美元。富豪貝洛伊特上交易期尾盤報139.83美元。

  • 在持有評級的情況下,Loop Capital在鐵姆肯公司紐約證券交易所代碼:TKR)。鐵姆肯的目標價似乎被設定在72.00美元。鐵姆肯第二季度每股收益為1.37美元,而去年同期為1.02美元。該股目前的52周高點為92.39美元,52周低點為52.51美元。上交易期尾盤,鐵姆肯收報66.61美元。

  • 在獲得買入評級的情況下,Stifel在Repare治療公司(納斯達克:RPTX)。Repare治療公司的目標價格似乎被設定在48.00美元。Repare治療公司第二季度的利潤為0.71美元,而去年同期為2.45美元。Repare Treeutics目前的股票表現顯示,52周高點為46.44美元,52周低點為21.76美元。而且,在上個交易期結束時,收盤價為28.48美元。

  • 在獲得買入評級的情況下,Stifel在米拉蒂治療公司(納斯達克:MRTX)。米拉蒂治療公司的目標價格似乎被設定在202.00美元。在第二季度,Mirati治療公司顯示每股收益為3.23美元,而去年同期為1.89美元。目前,該股的52周高點為249.42美元,52周低點為131.47美元。米拉蒂治療公司上一交易期尾盤收報167.10美元。

  • Stifel在Kinnate Biophma Inc.(納斯達克:KNTE),評級為買入。Kinnate Biophma的目標價定為32.00美元。Kinnate Biophma第二季度盈利0.49美元,而去年同期為2.05美元。該股目前的52周高點為48.75美元,52周低點為17.58美元。上交易期尾盤,Kinnate Biophma收報23.44美元。

  • 憑藉買入評級,Needham在爵士製藥公司(Jazz PharmPharmticals PLC)(納斯達克:爵士樂)。Jazz PharmPharmticals的目標價似乎被設定在220.00美元。第二季度,Jazz PharmPharmticals的每股收益為3.90美元,而去年同期為3.71美元。Jazz PharmPharmticals目前的股票表現顯示,52周高點為189.00美元,52周低點為127.80美元。而且,在上個交易期結束時,收盤價為129.55美元。

  • 李約瑟發起了關於Avadel製藥公司(納斯達克:AVDL),評級為買入。Avadel PharmPharmticals的目標價定為17.00美元。第二季度,Avadel製藥公司的每股收益為0.33美元,而去年同期為0.12美元。目前,該股的52周高點為10.32美元,52周低點為4.83美元。Avadel PharmPharmticals上一交易期尾盤報8.19美元。

  • 憑藉買入評級,Needham在賽奇治療公司(Sage Treateutics Inc.)(納斯達克:聖人)。Sage治療公司的目標價格似乎被設定在84.00美元。在第二季度,Sage治療公司顯示每股收益為1.83美元,而去年同期為2.08美元。Sage Treeutics目前的股票表現顯示,52周高點為98.39美元,52周低點為39.77美元。而且,在上個交易期結束時,收盤價為44.35美元。

  • 李約瑟發起了關於細胞內治療公司(納斯達克:ITCI),評級為買入。細胞內療法的目標價格定為55.00美元。細胞內療法第二季度的利潤為0.85美元,而去年同期為0.96美元。目前細胞內療法的股票表現顯示,52周高點為44.80美元,52周低點為22.91美元。而且,在上個交易期結束時,收盤價為37.17美元。

  • 憑藉買入評級,Needham在和諧生物科學控股有限公司(納斯達克:HRMY)。Harmony Biosciences的目標價似乎被設定在57.00美元。有趣的是,第二季度,Harmony Biosciences的每股收益為0.54美元。該股52周高點為52.74美元,52周低點為25.09美元。上一交易期尾盤,Harmony Biosciences收報37.46美元。

  • 李約瑟發起了關於生物遺傳公司(納斯達克:BIIB),評級為買入。生物遺傳公司的目標價格定為400.00美元。第二季度,Biogen的每股收益為5.68美元,而去年同期為10.26美元。目前,該股的52周高點為468.55美元,52周低點為223.25美元。生物遺傳研究公司上一交易期尾盤報289.32美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論